Anda belum login :: 01 Feb 2023 17:08 WIB
Detail
ArtikelLower Serum Level of Anti-tetanus Toxin Antibodies in Patientswith Type 2 Diabetes Mellitus  
Oleh: Nemati, M. ; Zarrin, M. ; Mir-Abdollah, S.A. ; Rezayati, M.T.
Jenis: Article from Journal - ilmiah nasional - terakreditasi DIKTI
Dalam koleksi: Acta Medica Indonesiana vol. 46 no. 01 (Jan. 2014), page 44-50.
Topik: circulating endothelial cells (CEC); nuclear factor kappa beta (NF?B); peripheral blood mononuclear cell (PBMC); vascular disease
Fulltext: 24760808.pdf (320.09KB)
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: A02.K
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelELISA method. The serum antitoxin concentration =0.1 IU/mL was considered as a protective level of antibody. Results: the seroprotective rate in healthy group was significantly higher than diabetic group (99% vs. 92%; p<0.02). The mean titer of anti-TTA in healthy group (5.32±0.26 IU/ml) was also significantly higher than diabetic patients (3.46±0.26 IU/ml; p<0.001). In diabetic men the mean titer of anti-TTA was significantly higher in comparison to diabetic women (3.94±0.34 IU/ml vs 2.59±0.36 IU/ml; p<0.01). In diabetic patients the seroprotective rate and the mean titer of anti-TTA in subjects with age >40 years was also lower in comparison to those with age <40 years (89.23% vs 97.14%; p<0.15 and 4.57±0.38 IU/ml vs 2.86±0.32 IU/ml; P<0.002, respectively). The mean titer of anti-TTA was significantly higher in patients with diabetes duration <5 years in comparison to patients with disease duration >5 years (3.91±0.35 IU/ml vs 2.85±0.38 IU/ml; p<0.04). Conclusion: these results showed lower levels of anti-TTA in patients with type 2 DM, in diabetic women, in patients aged >40 years and in diabetic patients with disease duration >5 years .
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)